Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Another significantly lower open expected as FED fallout continues
    • Market Update

    Another significantly lower open expected as FED fallout continues

    The XJO is expected to open lower this morning following extend falls in the U.S overnight. Their futures are flat. Our expected open is just below 7,000. 6,900 is roughly the lowest our market has traded at since late 2022. 7,000 and 6,950 are both key levels of support. With today’s move it is hard

    Read More
    Public
  • Waste-case scenario: Clean TeQ to acquire dewatering tech ATA for $3m for mine waste management
    • News

    Waste-case scenario: Clean TeQ to acquire dewatering tech ATA for $3m for mine waste management

    A 2023 survey found that, in the coming years, water management will be a top environmental concern among mining investors, with decarbonisation following closely behind. Investors expect miners to make better decisions, and water solutions treatment company Clean TeQ (ASX: CNQ) wants to help miners do so. The Company has decided to acquire accelerated dewatering

    Read More
    Public
  • PARKD signs exclusivity agreement with BlueScope’s Fielders to distribute IP and build products together
    • News

    PARKD signs exclusivity agreement with BlueScope’s Fielders to distribute IP and build products together

    Step into IKEA, and you see trolleys filled to the brim with flat-packed items (there could be an entire home there). This flat pack enables a do-it-yourself building attitude, also making portability affordable. Now imagine if the same could extend to construction, where builders would just receive flat packed elements that they would need to

    Read More
    Public
  • Race Oncology’s cancer drug demonstrates 86% boost in increasing cell-killing activity
    • News

    Race Oncology’s cancer drug demonstrates 86% boost in increasing cell-killing activity

    “Cancer” encompasses approximately 200 distinct disease types, and finding a single cure for all of them is unlikely. Each type of cancer requires a unique treatment approach, so there isn’t one universal cure. However, a recent study by Race Oncology (ASX: RAC) suggests a glimmer of hope, as its lead drug bisantrene has demonstrated strong

    Read More
    Public
  • Fed keeps rates on hold but signals another rise in future
    • Market Update

    Fed keeps rates on hold but signals another rise in future

    The XJO is expected to edge lower on open this morning following a selldown in the U.S overnight. The negativity heading into their close was largely brought about by the Fed’s future guidance update on monetary policy. We sold off yesterday in anticipation of a negative reaction from the U.S. Coupled with the past few

    Read More
    Public
  • Australian Government brings Micro-X’s Rover on board for X-ray imaging
    • News

    Australian Government brings Micro-X’s Rover on board for X-ray imaging

    Australian X-ray technology company Micro-X (ASX: MX1), known for its cold cathode X-ray technology used in health and security applications, has secured a Purchase Order worth $1.5 million from the Australian Government for its portable X-ray imaging tech Micro-X Rover systems.  These Rover units are currently in stock and will go through final adjustments in

    Read More
    Public
  • «
  • ‹
  • 180
  • 181
  • 182
  • 183
  • 184
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.